Pfizer
Pfizer-BioNTech COVID-19 vaccine likely to protect against UK variant, study says
January 20, 2021Research and Development COVID-19, Pfizer
The Pfizer-BioNTech COVID-19 vaccine is likely to protect against the coronavirus variant found in Britain, the latest research says. The …
COVID-19 vaccine data leaked online by hackers, EMA says
January 14, 2021EMA, Pfizer, Vaccine, data
The EMA has confirmed that data relating to COVID-19 medicines and vaccines that was stolen by hackers in December have …
Pfizer invests $25m in Vedanta BioSciences’ IBD treatment
January 13, 2021Research and Development Pfizer, Vedanta Biosciences, inflammatory bowel disease
Pfizer has invested $25 million in Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases, …
Pfizer’s COVID-19 vaccine protects against variants, research shows
January 8, 2021Medical Communications COVID-19, Pfizer, Vaccine
Pfizer’s COVID-19 vaccine is effective against the two fast-spreading variants of the virus that emerged in the UK and South …
EU states to receive 100m extra doses of Pfizer-BioNTech vaccine
January 4, 2021Sales and Marketing COVID-19, EU, Pfizer, Vaccine
Pfizer and BioNTech have announced they will supply an additional 100 million doses of their COVID-19 vaccine, COMIRNATY, to the …
BioInvent receives $3m payment for antibodies selected by Pfizer
December 23, 2020Research and Development BioInvent, Cancer, Pfizer
BioInvent International, a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, …
Pfizer and Moderna test COVID-19 vaccines against new strain
December 22, 2020Manufacturing and Production COVID-19, Moderna, Pfizer, Vaccine
Pfizer and Moderna have begun testing their COVID-19 vaccines against the new, fast-spreading strain of the virus that was recently …
EU gives green light to Pfizer-BioNTech COVID-19 vaccine
December 22, 2020Manufacturing and Production COVID-19, EMA, Pfizer, Vaccine
The EMA has recommended the Pfizer-BioNTech COVID-19 vaccine for use across the EU’s 27 countries, with the first doses set …
FDA says Pfizer vaccine vials contain extra doses, boosting US supply
December 17, 2020Sales and Marketing COVID-19, FDA, Pfizer, Vaccine
The FDA has announced that extra doses contained in Pfizer COVID-19 vaccine vials could expand America’s supply of the jab …
Pfizer and Merck KGaA secure CHMP recommendation for Bavencio in Europe for first-line maintenance of urothelial carcinoma
December 14, 2020Sales and Marketing Bavencio, CHMP, EMA, Merck, Pfizer, pharma, urothelial carcinoma
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given its recommendation for …
Top Ten most popular articles on Pharmafile.com this week
December 11, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, COVID-19, Pfizer, Vaccine, pharma, top 10
With just around three weeks until the end of a long year, rapidly emerging news around the leading COVID-19 vaccine …
UK becomes first nation to approve Pfizer and BioNTech’s COVID-19 vaccine
December 2, 2020Research and Development, Sales and Marketing COVID-19, Pfizer, UK, Vaccine
The UK has become the first country worldwide to authorise Pfizer and BioNTech’s promising COVID-19 vaccine, the UK Government has …
EMA receives Pfizer and BioNTech’s filing for conditional approval of COVID-19 vaccine in Europe
December 1, 2020Manufacturing and Production, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine
Pfizer and BioNTech have officially submitted their application to secure conditional marketing authorisation to the European Medicines Agency (EMA) for …
Pfizer and BioNTech to request FDA Emergency Use Authorisation for their COVID-19 vaccine today
November 20, 2020Medical Communications, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech are reportedly gearing up to submit a formal application for Emergency Use Authorisation to the FDA later …
Pfizer/BioNTech’s COVID-19 vaccine shows up to 95% efficacy in final analysis, including in over-65s
November 18, 2020Research and Development BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech have backed up their promising interim Phase 3 data showing 90% efficacy for their COVID-19 vaccine candidate …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
